Summary
Structures and Sequence Alignment
The best structural homolog that predicted by 1. PB was
P11465
(Pregnancy-specific beta-1-glycoprotein 2) with a FATCAT P-Value: 1.08e-14 and RMSD of 1.72 angstrom. The sequence alignment identity is 24.0%.
Structural alignment shown in left. Query protein A8MTB9 colored as red in alignment, homolog P11465 colored as blue.
Query protein A8MTB9 is also shown in right top, homolog P11465 showed in right bottom. They are colored based on secondary structures.
A8MTB9 M-DLSRPRWS--L-WRRVFLMASLL-ACGICQASGQIFI-TQTLGI-KGYRTVVALDKVPEDVQEYSWYWG-AND-----SA----GNMIISHKPPSAQQ 83 P11465 MGPLSAPPCTEHIKWKGLLVTASLLNFWNL-PTTAQVTIEAQPPKVSEGKDVLLLVHNLPQNLTGYIWYKGQIRDLYHYITSYVVDGQIIIY-------- 91 A8MTB9 PGPMYTGRERVNREGSLLIRPTALNDTGNYTVRVVA-GNETQRATGW----LEVLELGSNLGISVNASSL--VENMDSVAADC--LTNVTNITWYVN--D 172 P11465 -GPAYSGRETAYSNASLLIQNVTREDAGSYTLHIIKRGDGTRGVTGYFTFTL-YLETPKP---SISSSNLNPREAMETVILTCDPETPDTSYQWWMNGQS 186 A8MTB9 VPTSSSDRMTISPDGKTLVILRVSRYDRT---IQCMIESFPEIFQRSERISLTVAYGPDYVLLRSNPDDFNGIVTAEIGSQVEMECICYSFLDLKYHWIH 269 P11465 LP--MTHRFQLSETNRTLFLFGVTKY--TAGPYECEIRNSGS-ASRSDPVTLNLLHGPD--LPRIHP-SYTNYRS---GDNLYLSCFANSNPPAQYSWTI 275 A8MTB9 NGSLLNFSDAKMNL--SSLAWEQMGRYRCTVENPVTQLIMYMDVRIQAPHEDLTCCPQRFLHLRIHGDVPHHADSAGWRLHLWSPDPCSDQPLLNQDKSG 367 P11465 NG---KFQQSGQNLFIPQITTKHSGLYVCSVRNSAT------------GEESSTS-----LTVKV---------SASTRIGL--------LPLLNPT--- 335 A8MTB9 SMSVHPRPEDKTRRASR 384 P11465 ----------------- 335
Go Annotations
1. PB indicates the go terms that are found by both PROST and BLAST.2. P indicates the go terms that are found by only PROST.
3. B indicates the go terms that are only annotated by BLAST.
Source | GO | Description |
---|---|---|
1. PB | GO:0007565 | female pregnancy |
1. PB | GO:0044319 | wound healing, spreading of cells |
1. PB | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules |
1. PB | GO:1903387 | positive regulation of homophilic cell adhesion |
1. PB | GO:1990782 | protein tyrosine kinase binding |
1. PB | GO:0015125 | bile acid transmembrane transporter activity |
1. PB | GO:0050860 | negative regulation of T cell receptor signaling pathway |
1. PB | GO:0001819 | positive regulation of cytokine production |
1. PB | GO:0030424 | axon |
1. PB | GO:1903670 | regulation of sprouting angiogenesis |
1. PB | GO:0030334 | regulation of cell migration |
1. PB | GO:0070372 | regulation of ERK1 and ERK2 cascade |
1. PB | GO:0005911 | cell-cell junction |
1. PB | GO:0031005 | filamin binding |
1. PB | GO:0019903 | protein phosphatase binding |
1. PB | GO:0033691 | sialic acid binding |
1. PB | GO:0090331 | negative regulation of platelet aggregation |
1. PB | GO:0009986 | cell surface |
1. PB | GO:0035577 | azurophil granule membrane |
1. PB | GO:0043116 | negative regulation of vascular permeability |
1. PB | GO:0009897 | external side of plasma membrane |
1. PB | GO:0005737 | cytoplasm |
1. PB | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules |
1. PB | GO:0043318 | negative regulation of cytotoxic T cell degranulation |
1. PB | GO:0070593 | dendrite self-avoidance |
1. PB | GO:0030054 | cell junction |
1. PB | GO:0016324 | apical plasma membrane |
1. PB | GO:0038158 | granulocyte colony-stimulating factor signaling pathway |
1. PB | GO:0070062 | extracellular exosome |
1. PB | GO:0015721 | bile acid and bile salt transport |
1. PB | GO:0031528 | microvillus membrane |
1. PB | GO:0007098 | centrosome cycle |
1. PB | GO:0030853 | negative regulation of granulocyte differentiation |
1. PB | GO:2001214 | positive regulation of vasculogenesis |
1. PB | GO:0005130 | granulocyte colony-stimulating factor receptor binding |
1. PB | GO:0070348 | negative regulation of brown fat cell proliferation |
1. PB | GO:0045671 | negative regulation of osteoclast differentiation |
1. PB | GO:0042130 | negative regulation of T cell proliferation |
1. PB | GO:0098742 | cell-cell adhesion via plasma-membrane adhesion molecules |
1. PB | GO:0016328 | lateral plasma membrane |
1. PB | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway |
1. PB | GO:0005912 | adherens junction |
1. PB | GO:0045717 | negative regulation of fatty acid biosynthetic process |
1. PB | GO:0032426 | stereocilium tip |
1. PB | GO:0045601 | regulation of endothelial cell differentiation |
1. PB | GO:0035325 | Toll-like receptor binding |
1. PB | GO:1903385 | regulation of homophilic cell adhesion |
1. PB | GO:0009925 | basal plasma membrane |
1. PB | GO:0038016 | insulin receptor internalization |
1. PB | GO:0035726 | common myeloid progenitor cell proliferation |
1. PB | GO:0051055 | negative regulation of lipid biosynthetic process |
1. PB | GO:0032692 | negative regulation of interleukin-1 production |
1. PB | GO:0014066 | regulation of phosphatidylinositol 3-kinase signaling |
1. PB | GO:0002859 | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target |
1. PB | GO:0002376 | immune system process |
1. PB | GO:0007155 | cell adhesion |
1. PB | GO:0001558 | regulation of cell growth |
1. PB | GO:0060312 | regulation of blood vessel remodeling |
1. PB | GO:0045216 | cell-cell junction organization |
1. PB | GO:0001568 | blood vessel development |
1. PB | GO:0042803 | protein homodimerization activity |
1. PB | GO:2000346 | negative regulation of hepatocyte proliferation |
1. PB | GO:0030246 | carbohydrate binding |
1. PB | GO:0035579 | specific granule membrane |
1. PB | GO:0031225 | anchored component of membrane |
1. PB | GO:0034116 | positive regulation of heterotypic cell-cell adhesion |
1. PB | GO:0042113 | B cell activation |
1. PB | GO:0001915 | negative regulation of T cell mediated cytotoxicity |
1. PB | GO:0019900 | kinase binding |
1. PB | GO:0010594 | regulation of endothelial cell migration |
1. PB | GO:0001818 | negative regulation of cytokine production |
1. PB | GO:1901143 | insulin catabolic process |
1. PB | GO:0098632 | cell-cell adhesion mediator activity |
1. PB | GO:0006469 | negative regulation of protein kinase activity |
1. PB | GO:0045779 | negative regulation of bone resorption |
1. PB | GO:0042802 | identical protein binding |
1. PB | GO:0070821 | tertiary granule membrane |
2. P | GO:0046007 | negative regulation of activated T cell proliferation |
2. P | GO:0033010 | paranodal junction |
2. P | GO:0019226 | transmission of nerve impulse |
2. P | GO:0001779 | natural killer cell differentiation |
2. P | GO:0032701 | negative regulation of interleukin-18 production |
2. P | GO:0060369 | positive regulation of Fc receptor mediated stimulatory signaling pathway |
2. P | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process |
2. P | GO:0001773 | myeloid dendritic cell activation |
2. P | GO:0045121 | membrane raft |
2. P | GO:0030010 | establishment of cell polarity |
2. P | GO:0086016 | AV node cell action potential |
2. P | GO:0005244 | voltage-gated ion channel activity |
2. P | GO:0002250 | adaptive immune response |
2. P | GO:0031338 | regulation of vesicle fusion |
2. P | GO:0032743 | positive regulation of interleukin-2 production |
2. P | GO:0003823 | antigen binding |
2. P | GO:0023035 | CD40 signaling pathway |
2. P | GO:1903556 | negative regulation of tumor necrosis factor superfamily cytokine production |
2. P | GO:0002517 | T cell tolerance induction |
2. P | GO:0060307 | regulation of ventricular cardiac muscle cell membrane repolarization |
2. P | GO:0035879 | plasma membrane lactate transport |
2. P | GO:0038064 | collagen receptor activity |
2. P | GO:0001812 | positive regulation of type I hypersensitivity |
2. P | GO:0019863 | IgE binding |
2. P | GO:0046684 | response to pyrethroid |
2. P | GO:0140081 | glycosylated region protein binding |
2. P | GO:0099054 | presynapse assembly |
2. P | GO:1902961 | positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process |
2. P | GO:0042127 | regulation of cell population proliferation |
2. P | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway |
2. P | GO:0030018 | Z disc |
2. P | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation |
2. P | GO:0042110 | T cell activation |
2. P | GO:0045176 | apical protein localization |
2. P | GO:0032693 | negative regulation of interleukin-10 production |
2. P | GO:0099061 | integral component of postsynaptic density membrane |
2. P | GO:0007267 | cell-cell signaling |
2. P | GO:0045576 | mast cell activation |
2. P | GO:1902683 | regulation of receptor localization to synapse |
2. P | GO:0035160 | maintenance of epithelial integrity, open tracheal system |
2. P | GO:0072672 | neutrophil extravasation |
2. P | GO:0010460 | positive regulation of heart rate |
2. P | GO:0032753 | positive regulation of interleukin-4 production |
2. P | GO:0010765 | positive regulation of sodium ion transport |
2. P | GO:0002819 | regulation of adaptive immune response |
2. P | GO:0033629 | negative regulation of cell adhesion mediated by integrin |
2. P | GO:0005272 | sodium channel activity |
2. P | GO:0001618 | virus receptor activity |
2. P | GO:0032690 | negative regulation of interleukin-1 alpha production |
2. P | GO:0060048 | cardiac muscle contraction |
2. P | GO:0050777 | negative regulation of immune response |
2. P | GO:0001798 | positive regulation of type IIa hypersensitivity |
2. P | GO:2001204 | regulation of osteoclast development |
2. P | GO:0008542 | visual learning |
2. P | GO:0072659 | protein localization to plasma membrane |
2. P | GO:0086015 | SA node cell action potential |
2. P | GO:0007202 | activation of phospholipase C activity |
2. P | GO:0035725 | sodium ion transmembrane transport |
2. P | GO:0005886 | plasma membrane |
2. P | GO:1905404 | positive regulation of activated CD8-positive, alpha-beta T cell apoptotic process |
2. P | GO:0042104 | positive regulation of activated T cell proliferation |
2. P | GO:0035151 | regulation of tube size, open tracheal system |
2. P | GO:0006911 | phagocytosis, engulfment |
2. P | GO:0034987 | immunoglobulin receptor binding |
2. P | GO:0007520 | myoblast fusion |
2. P | GO:2001186 | negative regulation of CD8-positive, alpha-beta T cell activation |
2. P | GO:0019966 | interleukin-1 binding |
2. P | GO:0030889 | negative regulation of B cell proliferation |
2. P | GO:0050930 | induction of positive chemotaxis |
2. P | GO:2000439 | positive regulation of monocyte extravasation |
2. P | GO:2000556 | positive regulation of T-helper 1 cell cytokine production |
2. P | GO:0061343 | cell adhesion involved in heart morphogenesis |
2. P | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity |
2. P | GO:0001540 | amyloid-beta binding |
2. P | GO:0040011 | locomotion |
2. P | GO:0005055 | laminin receptor activity |
2. P | GO:1905449 | regulation of Fc-gamma receptor signaling pathway involved in phagocytosis |
2. P | GO:0060077 | inhibitory synapse |
2. P | GO:0010596 | negative regulation of endothelial cell migration |
2. P | GO:0014911 | positive regulation of smooth muscle cell migration |
2. P | GO:0042734 | presynaptic membrane |
2. P | GO:0007259 | receptor signaling pathway via JAK-STAT |
2. P | GO:1900271 | regulation of long-term synaptic potentiation |
2. P | GO:0008045 | motor neuron axon guidance |
2. P | GO:0150104 | transport across blood-brain barrier |
2. P | GO:0060291 | long-term synaptic potentiation |
2. P | GO:0019772 | low-affinity IgG receptor activity |
2. P | GO:0099560 | synaptic membrane adhesion |
2. P | GO:0007160 | cell-matrix adhesion |
2. P | GO:0050870 | positive regulation of T cell activation |
2. P | GO:1900273 | positive regulation of long-term synaptic potentiation |
2. P | GO:0098743 | cell aggregation |
2. P | GO:0004908 | interleukin-1 receptor activity |
2. P | GO:0014002 | astrocyte development |
2. P | GO:0150072 | positive regulation of arginase activity |
2. P | GO:0034706 | sodium channel complex |
2. P | GO:0098688 | parallel fiber to Purkinje cell synapse |
2. P | GO:0031226 | intrinsic component of plasma membrane |
2. P | GO:0072657 | protein localization to membrane |
2. P | GO:0005887 | integral component of plasma membrane |
2. P | GO:0043209 | myelin sheath |
2. P | GO:0010763 | positive regulation of fibroblast migration |
2. P | GO:0070160 | tight junction |
2. P | GO:0033624 | negative regulation of integrin activation |
2. P | GO:0045123 | cellular extravasation |
2. P | GO:0002765 | immune response-inhibiting signal transduction |
2. P | GO:0005178 | integrin binding |
2. P | GO:0050892 | intestinal absorption |
2. P | GO:0032735 | positive regulation of interleukin-12 production |
2. P | GO:0070374 | positive regulation of ERK1 and ERK2 cascade |
2. P | GO:0044325 | transmembrane transporter binding |
2. P | GO:2000145 | regulation of cell motility |
2. P | GO:0098942 | retrograde trans-synaptic signaling by trans-synaptic protein complex |
2. P | GO:0030425 | dendrite |
2. P | GO:1901216 | positive regulation of neuron death |
2. P | GO:0005248 | voltage-gated sodium channel activity |
2. P | GO:2000403 | positive regulation of lymphocyte migration |
2. P | GO:0002845 | positive regulation of tolerance induction to tumor cell |
2. P | GO:0007166 | cell surface receptor signaling pathway |
2. P | GO:0071639 | positive regulation of monocyte chemotactic protein-1 production |
2. P | GO:0090264 | regulation of immune complex clearance by monocytes and macrophages |
2. P | GO:2001256 | regulation of store-operated calcium entry |
2. P | GO:0098685 | Schaffer collateral - CA1 synapse |
2. P | GO:0044291 | cell-cell contact zone |
2. P | GO:2000509 | negative regulation of dendritic cell chemotaxis |
2. P | GO:0034113 | heterotypic cell-cell adhesion |
2. P | GO:1900272 | negative regulation of long-term synaptic potentiation |
2. P | GO:0150102 | negative regulation of monocyte activation |
2. P | GO:0050868 | negative regulation of T cell activation |
2. P | GO:0032731 | positive regulation of interleukin-1 beta production |
2. P | GO:0010759 | positive regulation of macrophage chemotaxis |
2. P | GO:0050901 | leukocyte tethering or rolling |
2. P | GO:0030971 | receptor tyrosine kinase binding |
2. P | GO:0086014 | atrial cardiac muscle cell action potential |
2. P | GO:0032689 | negative regulation of interferon-gamma production |
2. P | GO:0032695 | negative regulation of interleukin-12 production |
2. P | GO:0050862 | positive regulation of T cell receptor signaling pathway |
2. P | GO:0042102 | positive regulation of T cell proliferation |
2. P | GO:0090022 | regulation of neutrophil chemotaxis |
2. P | GO:0043220 | Schmidt-Lanterman incisure |
2. P | GO:0001811 | negative regulation of type I hypersensitivity |
2. P | GO:0050839 | cell adhesion molecule binding |
2. P | GO:0090557 | establishment of endothelial intestinal barrier |
2. P | GO:0086012 | membrane depolarization during cardiac muscle cell action potential |
2. P | GO:2000349 | negative regulation of CD40 signaling pathway |
2. P | GO:0001805 | positive regulation of type III hypersensitivity |
2. P | GO:0070379 | high mobility group box 1 binding |
2. P | GO:0019763 | immunoglobulin receptor activity |
2. P | GO:0002725 | negative regulation of T cell cytokine production |
2. P | GO:0007162 | negative regulation of cell adhesion |
2. P | GO:0005923 | bicellular tight junction |
2. P | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential |
2. P | GO:0032740 | positive regulation of interleukin-17 production |
2. P | GO:0051493 | regulation of cytoskeleton organization |
2. P | GO:0021966 | corticospinal neuron axon guidance |
2. P | GO:0090138 | regulation of actin cytoskeleton organization by cell-cell adhesion |
2. P | GO:0098609 | cell-cell adhesion |
2. P | GO:0086010 | membrane depolarization during action potential |
2. P | GO:0043507 | positive regulation of JUN kinase activity |
2. P | GO:0071663 | positive regulation of granzyme B production |
2. P | GO:0042552 | myelination |
2. P | GO:0033004 | negative regulation of mast cell activation |
2. P | GO:0002693 | positive regulation of cellular extravasation |
2. P | GO:0019227 | neuronal action potential propagation |
2. P | GO:1903829 | positive regulation of protein localization |
2. P | GO:0045334 | clathrin-coated endocytic vesicle |
2. P | GO:0050727 | regulation of inflammatory response |
2. P | GO:0002429 | immune response-activating cell surface receptor signaling pathway |
2. P | GO:0050790 | regulation of catalytic activity |
2. P | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I |
2. P | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway |
2. P | GO:0042267 | natural killer cell mediated cytotoxicity |
2. P | GO:0010976 | positive regulation of neuron projection development |
2. P | GO:0031941 | filamentous actin |
2. P | GO:0019884 | antigen processing and presentation of exogenous antigen |
2. P | GO:0005902 | microvillus |
2. P | GO:0045217 | cell-cell junction maintenance |
2. P | GO:0030110 | HLA-C specific inhibitory MHC class I receptor activity |
2. P | GO:0036477 | somatodendritic compartment |
2. P | GO:0032966 | negative regulation of collagen biosynthetic process |
2. P | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II |
2. P | GO:0034333 | adherens junction assembly |
2. P | GO:0031290 | retinal ganglion cell axon guidance |
2. P | GO:0001934 | positive regulation of protein phosphorylation |
2. P | GO:0086091 | regulation of heart rate by cardiac conduction |
2. P | GO:0071593 | lymphocyte aggregation |
2. P | GO:0032720 | negative regulation of tumor necrosis factor production |
2. P | GO:0032755 | positive regulation of interleukin-6 production |
2. P | GO:0001774 | microglial cell activation |
2. P | GO:0042129 | regulation of T cell proliferation |
2. P | GO:0002605 | negative regulation of dendritic cell antigen processing and presentation |
2. P | GO:0031642 | negative regulation of myelination |
2. P | GO:0035020 | regulation of Rac protein signal transduction |
2. P | GO:0098880 | maintenance of postsynaptic specialization structure |
2. P | GO:0030315 | T-tubule |
2. P | GO:1901215 | negative regulation of neuron death |
2. P | GO:1905522 | negative regulation of macrophage migration |
2. P | GO:0002266 | follicular dendritic cell activation |
2. P | GO:0002503 | peptide antigen assembly with MHC class II protein complex |
2. P | GO:2000510 | positive regulation of dendritic cell chemotaxis |
2. P | GO:0002028 | regulation of sodium ion transport |
2. P | GO:0032733 | positive regulation of interleukin-10 production |
2. P | GO:0035683 | memory T cell extravasation |
2. P | GO:1900744 | regulation of p38MAPK cascade |
2. P | GO:0150079 | negative regulation of neuroinflammatory response |
2. P | GO:1901731 | positive regulation of platelet aggregation |
2. P | GO:0005540 | hyaluronic acid binding |
2. P | GO:0032729 | positive regulation of interferon-gamma production |
2. P | GO:1904645 | response to amyloid-beta |
2. P | GO:1902414 | protein localization to cell junction |
2. P | GO:1900016 | negative regulation of cytokine production involved in inflammatory response |
2. P | GO:0032685 | negative regulation of granulocyte macrophage colony-stimulating factor production |
2. P | GO:1904861 | excitatory synapse assembly |
2. P | GO:1903615 | positive regulation of protein tyrosine phosphatase activity |
2. P | GO:0098636 | protein complex involved in cell adhesion |
2. P | GO:0035633 | maintenance of blood-brain barrier |
2. P | GO:1902564 | negative regulation of neutrophil activation |
2. P | GO:0086002 | cardiac muscle cell action potential involved in contraction |
2. P | GO:2000249 | regulation of actin cytoskeleton reorganization |
2. P | GO:0004910 | interleukin-1, type II, blocking receptor activity |
2. P | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization |
2. P | GO:0002891 | positive regulation of immunoglobulin mediated immune response |
2. P | GO:0051101 | regulation of DNA binding |
2. P | GO:0007165 | signal transduction |
2. P | GO:0010255 | glucose mediated signaling pathway |
2. P | GO:0048846 | axon extension involved in axon guidance |
2. P | GO:0031774 | leukotriene receptor binding |
2. P | GO:0043305 | negative regulation of mast cell degranulation |
2. P | GO:0033005 | positive regulation of mast cell activation |
2. P | GO:1904646 | cellular response to amyloid-beta |
2. P | GO:0002668 | negative regulation of T cell anergy |
2. P | GO:1900453 | negative regulation of long-term synaptic depression |
2. P | GO:0050766 | positive regulation of phagocytosis |
2. P | GO:0045590 | negative regulation of regulatory T cell differentiation |
2. P | GO:0086047 | membrane depolarization during Purkinje myocyte cell action potential |
2. P | GO:0032761 | positive regulation of lymphotoxin A production |
2. P | GO:0008037 | cell recognition |
2. P | GO:0005105 | type 1 fibroblast growth factor receptor binding |
2. P | GO:0045066 | regulatory T cell differentiation |
2. P | GO:0016323 | basolateral plasma membrane |
2. P | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity |
2. P | GO:0043031 | negative regulation of macrophage activation |
2. P | GO:0014704 | intercalated disc |
2. P | GO:0002316 | follicular B cell differentiation |
2. P | GO:0090559 | regulation of membrane permeability |
2. P | GO:0006955 | immune response |
2. P | GO:0006910 | phagocytosis, recognition |
2. P | GO:0033860 | regulation of NAD(P)H oxidase activity |
2. P | GO:0002313 | mature B cell differentiation involved in immune response |
2. P | GO:0030593 | neutrophil chemotaxis |
2. P | GO:0099059 | integral component of presynaptic active zone membrane |
2. P | GO:2000405 | negative regulation of T cell migration |
2. P | GO:0030057 | desmosome |
2. P | GO:0060101 | negative regulation of phagocytosis, engulfment |
2. P | GO:0002418 | immune response to tumor cell |
2. P | GO:0002270 | plasmacytoid dendritic cell activation |
2. P | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation |
2. P | GO:0038023 | signaling receptor activity |
2. P | GO:0051606 | detection of stimulus |
2. P | GO:0045777 | positive regulation of blood pressure |
2. P | GO:0031252 | cell leading edge |
2. P | GO:0097021 | lymphocyte migration into lymphoid organs |
2. P | GO:0002436 | immune complex clearance by monocytes and macrophages |
2. P | GO:0033595 | response to genistein |
2. P | GO:0030165 | PDZ domain binding |
2. P | GO:0001814 | negative regulation of antibody-dependent cellular cytotoxicity |
2. P | GO:0070945 | neutrophil-mediated killing of gram-negative bacterium |
2. P | GO:0045087 | innate immune response |
2. P | GO:0019864 | IgG binding |
2. P | GO:1905710 | positive regulation of membrane permeability |
2. P | GO:0001780 | neutrophil homeostasis |
2. P | GO:0042289 | MHC class II protein binding |
2. P | GO:0010955 | negative regulation of protein processing |
2. P | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway |
2. P | GO:1902623 | negative regulation of neutrophil migration |
2. P | GO:2000558 | positive regulation of immunoglobulin production in mucosal tissue |
2. P | GO:0061041 | regulation of wound healing |
2. P | GO:0032722 | positive regulation of chemokine production |
2. P | GO:0071222 | cellular response to lipopolysaccharide |
2. P | GO:0001518 | voltage-gated sodium channel complex |
2. P | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential |
2. P | GO:0051497 | negative regulation of stress fiber assembly |
2. P | GO:0007411 | axon guidance |
2. P | GO:0002860 | positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target |
2. P | GO:0045056 | transcytosis |
2. P | GO:0032760 | positive regulation of tumor necrosis factor production |
2. P | GO:0150003 | regulation of spontaneous synaptic transmission |
2. P | GO:1990138 | neuron projection extension |
2. P | GO:0051899 | membrane depolarization |
2. P | GO:0046641 | positive regulation of alpha-beta T cell proliferation |
2. P | GO:0097530 | granulocyte migration |
2. P | GO:0002769 | natural killer cell inhibitory signaling pathway |
2. P | GO:0019871 | sodium channel inhibitor activity |
2. P | GO:0031295 | T cell costimulation |
2. P | GO:0043236 | laminin binding |
2. P | GO:0005102 | signaling receptor binding |
2. P | GO:1903523 | negative regulation of blood circulation |
2. P | GO:0072714 | response to selenite ion |
2. P | GO:1902396 | protein localization to bicellular tight junction |
2. P | GO:0019233 | sensory perception of pain |
2. P | GO:0046330 | positive regulation of JNK cascade |
2. P | GO:0097241 | hematopoietic stem cell migration to bone marrow |
2. P | GO:1905150 | regulation of voltage-gated sodium channel activity |
2. P | GO:1990051 | activation of protein kinase C activity |
2. P | GO:2000649 | regulation of sodium ion transmembrane transporter activity |
2. P | GO:0033268 | node of Ranvier |
2. P | GO:2001199 | negative regulation of dendritic cell differentiation |
2. P | GO:0019767 | IgE receptor activity |
2. P | GO:1900745 | positive regulation of p38MAPK cascade |
2. P | GO:0002729 | positive regulation of natural killer cell cytokine production |
2. P | GO:0007611 | learning or memory |
2. P | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway |
2. P | GO:0032715 | negative regulation of interleukin-6 production |
2. P | GO:0050852 | T cell receptor signaling pathway |
2. P | GO:0150077 | regulation of neuroinflammatory response |
2. P | GO:0031103 | axon regeneration |
2. P | GO:0001914 | regulation of T cell mediated cytotoxicity |
2. P | GO:0086005 | ventricular cardiac muscle cell action potential |
2. P | GO:0001787 | natural killer cell proliferation |
2. P | GO:0034394 | protein localization to cell surface |
2. P | GO:0050853 | B cell receptor signaling pathway |
2. P | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion |
2. P | GO:0150074 | positive regulation of protein-glutamine gamma-glutamyltransferase activity |
2. P | GO:2000566 | positive regulation of CD8-positive, alpha-beta T cell proliferation |
2. P | GO:0099056 | integral component of presynaptic membrane |
2. P | GO:0002318 | myeloid progenitor cell differentiation |
2. P | GO:0043204 | perikaryon |
2. P | GO:0001817 | regulation of cytokine production |
2. P | GO:0001772 | immunological synapse |
2. P | GO:2001200 | positive regulation of dendritic cell differentiation |
2. P | GO:0050776 | regulation of immune response |
2. P | GO:0002523 | leukocyte migration involved in inflammatory response |
2. P | GO:0006909 | phagocytosis |
2. P | GO:2000353 | positive regulation of endothelial cell apoptotic process |
2. P | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules |
2. P | GO:0019770 | IgG receptor activity |
2. P | GO:0032703 | negative regulation of interleukin-2 production |
2. P | GO:0015026 | coreceptor activity |
2. P | GO:1905898 | positive regulation of response to endoplasmic reticulum stress |
2. P | GO:0002232 | leukocyte chemotaxis involved in inflammatory response |
2. P | GO:0001788 | antibody-dependent cellular cytotoxicity |
2. P | GO:0002485 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent |
2. P | GO:1901018 | positive regulation of potassium ion transmembrane transporter activity |
2. P | GO:0044548 | S100 protein binding |
2. P | GO:0007159 | leukocyte cell-cell adhesion |
2. P | GO:1903142 | positive regulation of establishment of endothelial barrier |
2. P | GO:0050785 | advanced glycation end-product receptor activity |
2. P | GO:0002639 | positive regulation of immunoglobulin production |
2. P | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin |
2. P | GO:0002336 | B-1 B cell lineage commitment |
2. P | GO:0045954 | positive regulation of natural killer cell mediated cytotoxicity |
2. P | GO:0002622 | regulation of B cell antigen processing and presentation |
2. P | GO:0098982 | GABA-ergic synapse |
2. P | GO:0001932 | regulation of protein phosphorylation |
2. P | GO:0007286 | spermatid development |
2. P | GO:0016021 | integral component of membrane |
2. P | GO:1904472 | positive regulation of endothelin production |
2. P | GO:2000514 | regulation of CD4-positive, alpha-beta T cell activation |
2. P | GO:0043184 | vascular endothelial growth factor receptor 2 binding |
2. P | GO:1904465 | negative regulation of matrix metallopeptidase secretion |
2. P | GO:0036057 | slit diaphragm |
2. P | GO:0030101 | natural killer cell activation |
2. P | GO:0043183 | vascular endothelial growth factor receptor 1 binding |
2. P | GO:0090647 | modulation of age-related behavioral decline |
2. P | GO:2000810 | regulation of bicellular tight junction assembly |
2. P | GO:0005829 | cytosol |
2. P | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation |
2. P | GO:0034260 | negative regulation of GTPase activity |
2. P | GO:0061337 | cardiac conduction |
2. P | GO:0001933 | negative regulation of protein phosphorylation |
2. P | GO:0004888 | transmembrane signaling receptor activity |
2. P | GO:0048143 | astrocyte activation |
2. P | GO:0002277 | myeloid dendritic cell activation involved in immune response |
2. P | GO:0001820 | serotonin secretion |
2. P | GO:0099557 | trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission |
2. P | GO:0072540 | T-helper 17 cell lineage commitment |
2. P | GO:0046658 | anchored component of plasma membrane |
2. P | GO:0042169 | SH2 domain binding |
2. P | GO:0060370 | susceptibility to T cell mediated cytotoxicity |
2. P | GO:0017080 | sodium channel regulator activity |
2. P | GO:0060100 | positive regulation of phagocytosis, engulfment |
2. P | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization |
2. P | GO:1901224 | positive regulation of NIK/NF-kappaB signaling |
2. P | GO:0001813 | regulation of antibody-dependent cellular cytotoxicity |
3. B | GO:0030198 | extracellular matrix organization |
3. B | GO:0005509 | calcium ion binding |
3. B | GO:0034613 | cellular protein localization |
3. B | GO:0060351 | cartilage development involved in endochondral bone morphogenesis |
3. B | GO:0072359 | circulatory system development |
3. B | GO:0009617 | response to bacterium |
3. B | GO:0060170 | ciliary membrane |
3. B | GO:0098797 | plasma membrane protein complex |
3. B | GO:0007420 | brain development |
3. B | GO:0060548 | negative regulation of cell death |
3. B | GO:2000252 | negative regulation of feeding behavior |
3. B | GO:0009888 | tissue development |
3. B | GO:0001525 | angiogenesis |
3. B | GO:0071636 | positive regulation of transforming growth factor beta production |
3. B | GO:0050849 | negative regulation of calcium-mediated signaling |
3. B | GO:0005604 | basement membrane |
3. B | GO:0019901 | protein kinase binding |
3. B | GO:0005796 | Golgi lumen |
3. B | GO:1905907 | negative regulation of amyloid fibril formation |
3. B | GO:0005819 | spindle |
3. B | GO:0010832 | negative regulation of myotube differentiation |
3. B | GO:0034109 | homotypic cell-cell adhesion |
3. B | GO:0008022 | protein C-terminus binding |
3. B | GO:0055037 | recycling endosome |
3. B | GO:0050859 | negative regulation of B cell receptor signaling pathway |
3. B | GO:0072686 | mitotic spindle |
3. B | GO:0040008 | regulation of growth |
3. B | GO:0002638 | negative regulation of immunoglobulin production |
3. B | GO:0006898 | receptor-mediated endocytosis |
3. B | GO:0007605 | sensory perception of sound |
3. B | GO:0030888 | regulation of B cell proliferation |
3. B | GO:0005813 | centrosome |
3. B | GO:2000811 | negative regulation of anoikis |
3. B | GO:0030021 | extracellular matrix structural constituent conferring compression resistance |
3. B | GO:0048738 | cardiac muscle tissue development |
3. B | GO:0030496 | midbody |
3. B | GO:0005576 | extracellular region |
3. B | GO:1904906 | positive regulation of endothelial cell-matrix adhesion via fibronectin |
3. B | GO:0031012 | extracellular matrix |
3. B | GO:0043406 | positive regulation of MAP kinase activity |
3. B | GO:0003779 | actin binding |
3. B | GO:0030133 | transport vesicle |
3. B | GO:0062023 | collagen-containing extracellular matrix |
3. B | GO:0034235 | GPI anchor binding |
3. B | GO:0032869 | cellular response to insulin stimulus |
3. B | GO:0005615 | extracellular space |
3. B | GO:0042609 | CD4 receptor binding |
3. B | GO:0005516 | calmodulin binding |
3. B | GO:0001791 | IgM binding |
3. B | GO:0032154 | cleavage furrow |
3. B | GO:0071575 | integral component of external side of plasma membrane |
3. B | GO:0009887 | animal organ morphogenesis |
3. B | GO:0045545 | syndecan binding |
Homologs
1. PB indicates the homologs that are found by both PROST and BLAST.
2. P indicates homologs that are only found by PROST.
3. B indicates homologs that are only found by BLAST.
Source | Homolog | Description | FATCAT p-val | PROST Evalue | BLAST Evalue |
---|---|---|---|---|---|
1. PB | P11464 | Pregnancy-specific beta-1-glycoprotein 1 | 1.76e-07 | 4.38e-06 | 1.93e-08 |
1. PB | Q925P2 | Carcinoembryonic antigen-related cell adhesion molecule 2 | 1.72e-10 | 2.27e-13 | 1.70e-20 |
1. PB | Q9D871 | Carcinoembryonic antigen-related cell adhesion molecule 18 | 4.82e-13 | 3.34e-26 | 6.21e-144 |
1. PB | Q16557 | Pregnancy-specific beta-1-glycoprotein 3 | 6.14e-07 | 1.68e-10 | 7.69e-08 |
1. PB | P11465 | Pregnancy-specific beta-1-glycoprotein 2 | 1.08e-14 | 3.71e-07 | 3.67e-14 |
1. PB | P40199 | Carcinoembryonic antigen-related cell adhesion molecule 6 | 9.99e-08 | 2.36e-04 | 7.49e-28 |
1. PB | A6QQC6 | HEPACAM family member 2 | 4.18e-06 | 6.80e-03 | 4.07e-05 |
1. PB | D3ZQE1 | Carcinoembryonic antigen-related cell adhesion molecule 16 | 4.11e-12 | 1.97e-02 | 4.08e-22 |
1. PB | A8MVW5 | HEPACAM family member 2 | 4.90e-07 | 2.33e-05 | 0.002 |
1. PB | E9QA28 | Carcinoembryonic antigen-related cell adhesion molecule 16 | 1.02e-11 | 4.05e-04 | 1.45e-20 |
1. PB | Q6UY09 | Carcinoembryonic antigen-related cell adhesion molecule 20 | 1.98e-05 | 2.91e-02 | 5.96e-13 |
1. PB | Q9UQ74 | Pregnancy-specific beta-1-glycoprotein 8 | 2.07e-08 | 1.32e-09 | 4.48e-09 |
1. PB | Q4VAH7 | HEPACAM family member 2 | 3.65e-08 | 1.60e-05 | 2.89e-05 |
1. PB | P16573 | Carcinoembryonic antigen-related cell adhesion molecule 1 | 2.72e-08 | 6.29e-10 | 1.59e-17 |
1. PB | Q9D2Z1 | Carcinoembryonic antigen-related cell adhesion molecule 20 | 1.18e-04 | 2.60e-02 | 5.04e-13 |
1. PB | Q14002 | Carcinoembryonic antigen-related cell adhesion molecule 7 | 5.05e-06 | 2.78e-03 | 1.08e-15 |
1. PB | P31809 | Carcinoembryonic antigen-related cell adhesion molecule 1 | 8.59e-10 | 4.14e-11 | 3.03e-15 |
1. PB | Q13046 | Putative pregnancy-specific beta-1-glycoprotein 7 | 5.01e-08 | 1.34e-09 | 2.31e-06 |
1. PB | Q00887 | Pregnancy-specific beta-1-glycoprotein 9 | 3.60e-09 | 1.16e-11 | 1.34e-06 |
1. PB | Q00888 | Pregnancy-specific beta-1-glycoprotein 4 | 1.68e-08 | 6.60e-08 | 6.77e-09 |
1. PB | Q15238 | Pregnancy-specific beta-1-glycoprotein 5 | 3.27e-13 | 1.77e-06 | 2.54e-18 |
1. PB | Q00889 | Pregnancy-specific beta-1-glycoprotein 6 | 2.12e-07 | 4.98e-13 | 2.96e-10 |
1. PB | P31997 | Carcinoembryonic antigen-related cell adhesion molecule 8 | 4.48e-10 | 7.30e-06 | 8.37e-27 |
1. PB | A8MTB9 | Carcinoembryonic antigen-related cell adhesion molecule 18 | 0 | 1.20e-134 | 0.0 |
1. PB | P13688 | Carcinoembryonic antigen-related cell adhesion molecule 1 | 1.04e-06 | 1.80e-09 | 5.18e-25 |
1. PB | Q9UQ72 | Pregnancy-specific beta-1-glycoprotein 11 | 8.97e-10 | 2.66e-05 | 3.73e-15 |
1. PB | Q3KPI0 | Carcinoembryonic antigen-related cell adhesion molecule 21 | 4.13e-06 | 7.51e-10 | 2.36e-13 |
2. P | Q96NY8 | Nectin-4 | 8.05e-08 | 3.49e-03 | NA |
2. P | Q9MYX7 | Cytotoxic T-lymphocyte protein 4 | 3.61e-02 | 3.69e-04 | NA |
2. P | P43626 | Killer cell immunoglobulin-like receptor 2DL1 | 6.98e-03 | 3.57e-02 | NA |
2. P | Q7ZXX1 | Cell adhesion molecule 3 | 5.01e-05 | 3.27e-06 | NA |
2. P | O46631 | Tyrosine-protein phosphatase non-receptor type substrate 1 | 1.35e-03 | 2.28e-02 | NA |
2. P | P27930 | Interleukin-1 receptor type 2 | 1.20e-05 | 5.96e-04 | NA |
2. P | A5A6L6 | Sodium channel subunit beta-1 | 9.42e-03 | 9.00e-03 | NA |
2. P | A7XUX6 | Selection and upkeep of intraepithelial T-cells protein 2 | 2.09e-02 | 2.97e-02 | NA |
2. P | P50895 | Basal cell adhesion molecule | 2.51e-04 | 4.14e-07 | NA |
2. P | Q92637 | High affinity immunoglobulin gamma Fc receptor IB | 1.57e-03 | 2.73e-02 | NA |
2. P | G5EGI7 | Zwei Ig domain protein zig-1 | 6.90e-03 | 1.19e-03 | NA |
2. P | P35737 | Class II histocompatibility antigen, M beta 1 chain | 1.45e-01 | 4.75e-02 | NA |
2. P | Q9ESS6 | Basal cell adhesion molecule | 1.65e-04 | 1.67e-02 | NA |
2. P | Q9BH13 | CD166 antigen | 4.42e-05 | 2.75e-02 | NA |
2. P | Q90Y50 | Coxsackievirus and adenovirus receptor homolog | 5.69e-03 | 2.99e-02 | NA |
2. P | Q9NZQ7 | Programmed cell death 1 ligand 1 | 6.80e-03 | 4.89e-04 | NA |
2. P | P01902 | H-2 class I histocompatibility antigen, K-D alpha chain | 1.28e-01 | 1.97e-02 | NA |
2. P | Q14953 | Killer cell immunoglobulin-like receptor 2DS5 | 2.37e-03 | 3.81e-02 | NA |
2. P | P42071 | T-lymphocyte activation antigen CD86 | 1.96e-03 | 1.68e-05 | NA |
2. P | Q9R069 | Basal cell adhesion molecule | 2.68e-04 | 5.16e-04 | NA |
2. P | Q28125 | Intercellular adhesion molecule 3 | 1.08e-02 | 1.03e-02 | NA |
2. P | Q9JK00 | Sodium channel subunit beta-3 | 1.60e-03 | 4.51e-03 | NA |
2. P | Q86UW8 | Hyaluronan and proteoglycan link protein 4 | 7.73e-02 | 2.51e-02 | NA |
2. P | O43699 | Sialic acid-binding Ig-like lectin 6 | 8.61e-06 | 2.92e-03 | NA |
2. P | Q61490 | CD166 antigen | 7.21e-05 | 8.83e-03 | NA |
2. P | Q1WIM3 | Cell adhesion molecule 3 | 9.88e-06 | 4.06e-09 | NA |
2. P | Q5NKV6 | Intercellular adhesion molecule 1 | 3.92e-03 | 4.88e-02 | NA |
2. P | Q8R007 | Nectin-4 | 1.91e-06 | 3.19e-03 | NA |
2. P | Q63495 | Advanced glycosylation end product-specific receptor | 4.18e-06 | 1.17e-06 | NA |
2. P | P54900 | Sodium channel subunit beta-2 | 1.05e-02 | 3.81e-02 | NA |
2. P | Q9Y336 | Sialic acid-binding Ig-like lectin 9 | 1.54e-06 | 2.42e-02 | NA |
2. P | Q9BY67 | Cell adhesion molecule 1 | 5.26e-05 | 7.21e-05 | NA |
2. P | P97952 | Sodium channel subunit beta-1 | 9.49e-03 | 1.08e-02 | NA |
2. P | P10522 | Myelin protein P0 | 6.88e-03 | 5.70e-03 | NA |
2. P | Q1WIM1 | Cell adhesion molecule 4 | 1.12e-05 | 1.62e-09 | NA |
2. P | Q5NKU6 | Intercellular adhesion molecule 3 | 2.95e-02 | 4.05e-03 | NA |
2. P | Q80WM4 | Hyaluronan and proteoglycan link protein 4 | 2.80e-02 | 1.49e-03 | NA |
2. P | Q9D7L8 | Transmembrane and immunoglobulin domain-containing protein 1 | 7.12e-06 | 1.40e-05 | NA |
2. P | P23735 | Ig mu chain C region membrane-bound form | 7.08e-03 | 7.42e-03 | NA |
2. P | P0C788 | OX-2 membrane glycoprotein homolog | NA | 3.60e-05 | NA |
2. P | Q9NYZ4 | Sialic acid-binding Ig-like lectin 8 | 2.36e-06 | 1.16e-02 | NA |
2. P | O35112 | CD166 antigen | 4.39e-05 | 2.00e-02 | NA |
2. P | P32506 | Poliovirus receptor homolog | 1.19e-04 | 5.16e-06 | NA |
2. P | Q9Y639 | Neuroplastin | 2.07e-04 | 5.49e-03 | NA |
2. P | A0A0B4J1G0 | Low affinity immunoglobulin gamma Fc region receptor IV | 2.71e-04 | 4.14e-02 | NA |
2. P | Q68FQ2 | Junctional adhesion molecule C | 1.31e-02 | 7.23e-07 | NA |
2. P | Q9XSI1 | Cytotoxic T-lymphocyte protein 4 | 4.15e-02 | 6.22e-04 | NA |
2. P | Q9JHJ8 | ICOS ligand | 6.35e-03 | 4.07e-05 | NA |
2. P | P27931 | Interleukin-1 receptor type 2 | 2.66e-05 | 2.89e-04 | NA |
2. P | Q28110 | Low affinity immunoglobulin gamma Fc region receptor II | 1.32e-03 | 1.61e-02 | NA |
2. P | P42070 | T-lymphocyte activation antigen CD80 | 2.60e-03 | 1.53e-05 | NA |
2. P | Q18PI6 | SLAM family member 5 | 9.57e-04 | 1.15e-04 | NA |
2. P | Q99795 | Cell surface A33 antigen | 1.95e-02 | 4.44e-05 | NA |
2. P | Q9QUM4 | Signaling lymphocytic activation molecule | 1.28e-03 | 5.89e-07 | NA |
2. P | P57087 | Junctional adhesion molecule B | 1.18e-02 | 1.66e-03 | NA |
2. P | Q91664 | V-set and immunoglobulin domain-containing protein 1 | 1.53e-03 | 8.74e-03 | NA |
2. P | Q9NQ25 | SLAM family member 7 | 1.08e-02 | 9.18e-03 | NA |
2. P | Q8MJ02 | Natural cytotoxicity triggering receptor 3 | 5.31e-02 | 2.53e-02 | NA |
2. P | P78410 | Butyrophilin subfamily 3 member A2 | 9.33e-03 | 7.47e-06 | NA |
2. P | D3YX43 | V-set and immunoglobulin domain-containing protein 10 | 1.33e-03 | 6.93e-03 | NA |
2. P | Q96A28 | SLAM family member 9 | 1.81e-05 | 3.11e-02 | NA |
2. P | P31042 | T-cell-specific surface glycoprotein CD28 | 8.70e-02 | 6.67e-03 | NA |
2. P | Q8K4F0 | CD226 antigen | 1.25e-03 | 3.24e-06 | NA |
2. P | Q66KX2 | Cell adhesion molecule 4 | 4.63e-05 | 1.21e-07 | NA |
2. P | P42072 | Cytotoxic T-lymphocyte protein 4 | 2.88e-02 | 3.35e-03 | NA |
2. P | Q9JHY1 | Junctional adhesion molecule A | 4.64e-04 | 2.04e-04 | NA |
2. P | Q18806 | Neuronal immunoglobulin domain-containing protein rig-3 | 2.23e-03 | 2.31e-02 | NA |
2. P | Q8TD46 | Cell surface glycoprotein CD200 receptor 1 | 1.88e-03 | 9.90e-05 | NA |
2. P | Q9ES58 | Cell surface glycoprotein CD200 receptor 1 | 1.19e-03 | 1.01e-05 | NA |
2. P | Q68EV1 | CD276 antigen homolog | 1.20e-02 | 1.09e-05 | NA |
2. P | Q91Y57 | Sialic acid-binding Ig-like lectin 12 | 3.94e-06 | 7.21e-05 | NA |
2. P | Q9NY72 | Sodium channel subunit beta-3 | 1.61e-03 | 1.90e-03 | NA |
2. P | Q8N743 | Killer cell immunoglobulin-like receptor 3DL3 | 2.00e-04 | 3.67e-02 | NA |
2. P | Q61790 | Lymphocyte activation gene 3 protein | 1.10e-04 | 1.37e-04 | NA |
2. P | P12319 | High affinity immunoglobulin epsilon receptor subunit alpha | 1.14e-03 | 1.28e-03 | NA |
2. P | Q6XJV6 | Cell surface glycoprotein CD200 receptor 2 | 1.25e-02 | 1.57e-05 | NA |
2. P | Q15762 | CD226 antigen | 2.69e-03 | 3.42e-04 | NA |
2. P | Q8HXJ7 | Sodium channel subunit beta-3 | 1.08e-03 | 1.41e-03 | NA |
2. P | A5D7C3 | Myelin protein zero-like protein 3 | 6.58e-03 | 2.12e-02 | NA |
2. P | Q00954 | Sodium channel subunit beta-1 | 9.28e-03 | 1.16e-02 | NA |
2. P | P08920 | T-cell surface antigen CD2 | 1.02e-02 | 2.80e-03 | NA |
2. P | Q96PQ1 | Sialic acid-binding Ig-like lectin 12 | 1.65e-04 | 2.37e-02 | NA |
2. P | P42292 | CD166 antigen | 9.46e-04 | 2.66e-05 | NA |
2. P | Q3T113 | Transmembrane and immunoglobulin domain-containing protein 1 | 1.82e-04 | 1.91e-07 | NA |
2. P | A0A0E4BZH1 | Selection and upkeep of intraepithelial T-cells protein 1 | 1.38e-02 | 1.53e-03 | NA |
2. P | Q95MM9 | Signaling lymphocytic activation molecule | 3.24e-03 | 1.24e-06 | NA |
2. P | P20138 | Myeloid cell surface antigen CD33 | 1.61e-02 | 9.00e-03 | NA |
2. P | Q7YR73 | Inducible T-cell costimulator | 2.42e-01 | 6.29e-03 | NA |
2. P | Q5E9Z9 | Nectin-4 | 1.21e-07 | 2.88e-02 | NA |
2. P | Q64JA4 | Sialic acid-binding Ig-like lectin 13 | 2.55e-07 | 3.66e-07 | NA |
2. P | O95297 | Myelin protein zero-like protein 1 | 7.61e-02 | 4.33e-03 | NA |
2. P | Q96DU3 | SLAM family member 6 | 4.36e-03 | 3.60e-06 | NA |
2. P | Q6UXZ0 | Transmembrane and immunoglobulin domain-containing protein 1 | 4.92e-05 | 3.02e-06 | NA |
2. P | Q13291 | Signaling lymphocytic activation molecule | 7.39e-04 | 1.08e-05 | NA |
2. P | O14931 | Natural cytotoxicity triggering receptor 3 | 1.94e-02 | 1.95e-02 | NA |
2. P | Q5TFQ8 | Signal-regulatory protein beta-1 isoform 3 | 1.01e-04 | 9.91e-03 | NA |
2. P | A7XV04 | Selection and upkeep of intraepithelial T-cells protein 7 | 1.19e-02 | 7.28e-03 | NA |
2. P | Q8BLK3 | Limbic system-associated membrane protein | 1.83e-07 | 1.64e-08 | NA |
2. P | Q95132 | Intercellular adhesion molecule 1 | 1.71e-02 | 5.54e-03 | NA |
2. P | P61484 | Natural cytotoxicity triggering receptor 3 | 4.87e-03 | 3.19e-02 | NA |
2. P | Q99N28 | Cell adhesion molecule 3 | 1.62e-06 | 1.56e-09 | NA |
2. P | P11364 | Viral T-cell receptor beta chain-like T17T-22 | NA | 4.09e-07 | NA |
2. P | P27645 | Low affinity immunoglobulin gamma Fc region receptor III | 3.56e-03 | 3.50e-04 | NA |
2. P | Q9Z109 | V-set and immunoglobulin domain-containing protein 2 | 2.85e-03 | 8.09e-03 | NA |
2. P | P31994 | Low affinity immunoglobulin gamma Fc region receptor II-b | 3.40e-04 | 1.91e-02 | NA |
2. P | Q90773 | Protein CEPU-1 | 5.99e-07 | 9.91e-03 | NA |
2. P | Q7TPB4 | CD276 antigen | 1.86e-03 | 4.68e-07 | NA |
2. P | O75144 | ICOS ligand | 3.18e-03 | 7.54e-05 | NA |
2. P | P43303 | Interleukin-1 receptor type 2 | 1.82e-05 | 1.08e-02 | NA |
2. P | Q6GMZ9 | V-set and immunoglobulin domain-containing protein 10 | 2.11e-03 | 7.26e-04 | NA |
2. P | A3KPA0 | Junctional adhesion molecule 3B | 1.74e-03 | 1.97e-02 | NA |
2. P | Q2KI11 | Sodium channel subunit beta-3 | 1.40e-03 | 6.17e-03 | NA |
2. P | P04218 | OX-2 membrane glycoprotein | 4.64e-05 | 3.70e-02 | NA |
2. P | Q6WEB5 | Myelin protein P0 | 8.83e-03 | 4.33e-03 | NA |
2. P | P53788 | Sodium channel subunit beta-1 | 9.38e-03 | 4.84e-04 | NA |
2. P | O00241 | Signal-regulatory protein beta-1 | 3.54e-04 | 7.73e-04 | NA |
2. P | Q8R5M8 | Cell adhesion molecule 1 | 1.09e-04 | 1.50e-03 | NA |
2. P | Q9JKE2 | Triggering receptor expressed on myeloid cells 1 | 1.64e-02 | 1.21e-02 | NA |
2. P | Q9XT56 | Junctional adhesion molecule A | 9.69e-04 | 9.11e-04 | NA |
2. P | Q8BHK6 | SLAM family member 7 | 3.93e-03 | 1.03e-04 | NA |
2. P | Q9Y286 | Sialic acid-binding Ig-like lectin 7 | 7.36e-06 | 2.86e-04 | NA |
2. P | Q08E08 | Sodium channel subunit beta-4 | 2.22e-02 | 3.49e-03 | NA |
2. P | Q24372 | Lachesin | 3.74e-05 | 3.77e-06 | NA |
2. P | Q5BK54 | Lymphocyte activation gene 3 protein | 8.29e-05 | 3.59e-03 | NA |
2. P | Q9EP73 | Programmed cell death 1 ligand 1 | 3.29e-03 | 6.50e-06 | NA |
2. P | P30816 | Envelope glycoprotein E | NA | 2.99e-02 | NA |
2. P | Q8BHK2 | Sodium channel subunit beta-3 | 1.63e-03 | 1.48e-02 | NA |
2. P | Q15109 | Advanced glycosylation end product-specific receptor | 5.90e-05 | 1.61e-06 | NA |
2. P | P06907 | Myelin protein P0 | 1.02e-02 | 1.60e-02 | NA |
2. P | Q96IQ7 | V-set and immunoglobulin domain-containing protein 2 | 6.11e-03 | 9.27e-03 | NA |
2. P | Q6AYP5 | Cell adhesion molecule 1 | 8.28e-05 | 3.28e-02 | NA |
2. P | Q6Q8B3 | Cell surface glycoprotein CD200 receptor 2 | 4.19e-03 | 3.35e-03 | NA |
2. P | Q9P1W8 | Signal-regulatory protein gamma | 2.04e-04 | 3.44e-02 | NA |
2. P | Q5JXA9 | Signal-regulatory protein beta-2 | 1.84e-03 | 8.74e-04 | NA |
2. P | Q92154 | Schwann cell myelin protein | 3.84e-04 | 8.93e-04 | NA |
2. P | Q9JI59 | Junctional adhesion molecule B | 1.37e-02 | 2.57e-05 | NA |
2. P | Q9JK39 | Butyrophilin-like protein 10 | 1.61e-03 | 2.10e-04 | NA |
2. P | P26151 | High affinity immunoglobulin gamma Fc receptor I | 6.25e-05 | 4.97e-03 | NA |
2. P | Q95LH0 | Sialic acid-binding Ig-like lectin 12 | 1.14e-04 | 1.26e-02 | NA |
2. P | Q8IYS5 | Osteoclast-associated immunoglobulin-like receptor | 5.78e-04 | 2.08e-04 | NA |
2. P | Q9JLM2 | Natural killer cell receptor 2B4 | 1.06e-04 | 3.08e-04 | NA |
2. P | Q96LA5 | Fc receptor-like protein 2 | 4.73e-04 | 3.70e-02 | NA |
2. P | P08508 | Low affinity immunoglobulin gamma Fc region receptor III | 2.44e-04 | 2.18e-03 | NA |
2. P | P97546 | Neuroplastin | 3.74e-04 | 1.95e-03 | NA |
2. P | Q9MZ08 | Basal cell adhesion molecule | 2.93e-04 | 1.56e-06 | NA |
2. P | Q8N126 | Cell adhesion molecule 3 | 9.37e-05 | 2.68e-08 | NA |
2. P | Q08ET2 | Sialic acid-binding Ig-like lectin 14 | 9.79e-07 | 1.41e-08 | NA |
2. P | P18627 | Lymphocyte activation gene 3 protein | 3.84e-05 | 9.43e-07 | NA |
2. P | Q9UM44 | HERV-H LTR-associating protein 2 | 2.52e-04 | 2.95e-04 | NA |
2. P | Q07699 | Sodium channel subunit beta-1 | 8.01e-03 | 9.00e-03 | NA |
2. P | Q96N03 | V-set and transmembrane domain-containing protein 2-like protein | 5.07e-02 | 4.88e-02 | NA |
2. P | Q56A07 | Sodium channel subunit beta-2 | 2.25e-03 | 1.81e-02 | NA |
2. P | Q28173 | Advanced glycosylation end product-specific receptor | 3.77e-05 | 2.22e-06 | NA |
2. P | Q62151 | Advanced glycosylation end product-specific receptor | 2.37e-05 | 2.63e-07 | NA |
2. P | P16410 | Cytotoxic T-lymphocyte protein 4 | 2.63e-02 | 3.93e-03 | NA |
2. P | Q9JKA5 | Cell surface A33 antigen | 1.33e-03 | 5.73e-05 | NA |
2. P | Q13740 | CD166 antigen | 4.83e-05 | 2.35e-02 | NA |
2. P | O88775 | Embigin | 1.05e-01 | 4.30e-05 | NA |
2. P | Q9ET39 | SLAM family member 6 | 6.62e-02 | 1.71e-11 | NA |
2. P | P25189 | Myelin protein P0 | 9.93e-03 | 7.42e-03 | NA |
2. P | P33681 | T-lymphocyte activation antigen CD80 | 3.56e-04 | 1.33e-02 | NA |
2. P | P26453 | Basigin | 1.20e-04 | 4.62e-02 | NA |
2. P | Q22125 | Zwei Ig domain protein zig-6 | 1.19e-04 | 2.18e-05 | NA |
2. P | Q6UX52 | Protein IL-40 | 5.87e-03 | 5.28e-06 | NA |
2. P | P18181 | CD48 antigen | 4.21e-06 | 1.29e-03 | NA |
2. P | Q4PPC4 | Sodium channel subunit beta-1 | 9.31e-03 | 1.16e-02 | NA |
2. P | P09793 | Cytotoxic T-lymphocyte protein 4 | 1.27e-01 | 1.97e-02 | NA |
2. P | O18906 | CD226 antigen | 3.46e-03 | 5.49e-04 | NA |
2. P | Q26474 | Lachesin | 3.60e-05 | 4.56e-07 | NA |
2. P | Q14952 | Killer cell immunoglobulin-like receptor 2DS3 | 6.71e-03 | 1.21e-02 | NA |
2. P | Q2YHT7 | Cell surface glycoprotein CD200 receptor 1-A | 1.84e-03 | 9.37e-05 | NA |
2. P | Q8N0Z9 | V-set and immunoglobulin domain-containing protein 10 | 4.07e-04 | 3.22e-02 | NA |
2. P | A6NMB1 | Sialic acid-binding Ig-like lectin 16 | 2.22e-05 | 8.65e-04 | NA |
2. P | Q6ZMC9 | Sialic acid-binding Ig-like lectin 15 | 2.77e-03 | 4.74e-04 | NA |
2. P | Q6PDS0 | V-set and transmembrane domain-containing protein 2-like protein | 1.85e-02 | 7.47e-06 | NA |
2. P | Q9D8B7 | Junctional adhesion molecule C | 7.23e-03 | 1.71e-06 | NA |
2. P | P42081 | T-lymphocyte activation antigen CD86 | 2.94e-03 | 1.11e-06 | NA |
2. P | Q9ES57 | Cell surface glycoprotein CD200 receptor 1 | 3.94e-03 | 2.34e-04 | NA |
2. P | P43628 | Killer cell immunoglobulin-like receptor 2DL3 | 3.79e-03 | 3.38e-02 | NA |
2. P | P10252 | CD48 antigen | 5.83e-06 | 2.24e-02 | NA |
2. P | Q6DJ83 | Cell adhesion molecule 2 | 9.49e-05 | 4.14e-02 | NA |
2. P | Q5UKY4 | Cell surface glycoprotein CD200 receptor 3 | 1.88e-02 | 7.38e-06 | NA |
2. P | Q9UIB8 | SLAM family member 5 | 3.44e-03 | 1.86e-02 | NA |
2. P | Q8NFZ8 | Cell adhesion molecule 4 | 1.02e-05 | 4.06e-09 | NA |
2. P | Q8VE98 | CD276 antigen | 2.60e-03 | 2.24e-07 | NA |
2. P | Q9BX67 | Junctional adhesion molecule C | 2.39e-03 | 2.47e-06 | NA |
2. P | Q2WGK2 | Junctional adhesion molecule A | 2.75e-03 | 7.26e-04 | NA |
2. P | Q0V881 | Lymphocyte antigen 6 complex locus protein G6f | 2.09e-02 | 1.08e-02 | NA |
2. P | Q9P0V8 | SLAM family member 8 | 1.03e-03 | 7.71e-03 | NA |
2. P | P27573 | Myelin protein P0 | 1.21e-02 | 1.28e-02 | NA |
2. P | Q00609 | T-lymphocyte activation antigen CD80 | 9.87e-04 | 1.08e-05 | NA |
2. P | Q17QN4 | Sodium channel subunit beta-1 | 8.07e-04 | 2.98e-03 | NA |
2. P | O88792 | Junctional adhesion molecule A | 9.29e-04 | 7.62e-05 | NA |
2. P | Q8R464 | Cell adhesion molecule 4 | 9.37e-05 | 2.13e-08 | NA |
2. P | P21995 | Embigin | 1.04e-01 | 1.41e-02 | NA |
2. P | Q29983 | MHC class I polypeptide-related sequence A | 1.70e-01 | 2.00e-02 | NA |
2. P | P43627 | Killer cell immunoglobulin-like receptor 2DL2 | 4.91e-03 | 3.05e-02 | NA |
2. P | P15151 | Poliovirus receptor | 1.32e-04 | 1.23e-06 | NA |
2. P | P42082 | T-lymphocyte activation antigen CD86 | 3.25e-03 | 1.77e-03 | NA |
2. P | P97300 | Neuroplastin | 2.81e-04 | 1.66e-02 | NA |
2. P | Q9BQ51 | Programmed cell death 1 ligand 2 | 2.54e-02 | 1.91e-04 | NA |
2. P | P32942 | Intercellular adhesion molecule 3 | 8.82e-03 | 1.73e-03 | NA |
3. B | Q8NDA2 | Hemicentin-2 | NA | NA | 5.58e-04 |
3. B | O95428 | Papilin | 5.78e-02 | NA | 0.002 |
3. B | A0A0B4J1L0 | Carcinoembryonic antigen-related cell adhesion molecule 15 | 1.04e-06 | NA | 6.48e-15 |
3. B | Q62845 | Contactin-4 | 1.11e-03 | NA | 0.042 |
3. B | Q9N1E5 | B-cell receptor CD22 (Fragment) | 5.65e-06 | NA | 0.008 |
3. B | Q05793 | Basement membrane-specific heparan sulfate proteoglycan core protein | NA | NA | 0.017 |
3. B | Q96RW7 | Hemicentin-1 | NA | NA | 5.14e-05 |
3. B | Q7Z692 | Carcinoembryonic antigen-related cell adhesion molecule 19 | 2.05e-03 | NA | 0.007 |
3. B | D3YXG0 | Hemicentin-1 | NA | NA | 2.04e-07 |
3. B | Q9N1E3 | B-cell receptor CD22 (Fragment) | 3.74e-06 | NA | 8.98e-04 |
3. B | Q2WEN9 | Carcinoembryonic antigen-related cell adhesion molecule 16 | 3.03e-12 | NA | 1.92e-21 |
3. B | P06731 | Carcinoembryonic antigen-related cell adhesion molecule 5 | 2.21e-08 | NA | 4.37e-24 |
3. B | Q810J1 | Pregnancy-specific glycoprotein 22 | 8.41e-09 | NA | 1.23e-11 |
3. B | P98160 | Basement membrane-specific heparan sulfate proteoglycan core protein | NA | NA | 0.017 |
3. B | Q3UKK2 | Carcinoembryonic antigen-related cell adhesion molecule 5 | 3.78e-05 | NA | 1.36e-05 |
3. B | Q9N1E6 | B-cell receptor CD22 (Fragment) | 6.66e-06 | NA | 0.008 |
3. B | P40198 | Carcinoembryonic antigen-related cell adhesion molecule 3 | 1.68e-03 | NA | 1.09e-06 |
3. B | Q640R3 | Hepatocyte cell adhesion molecule | 1.01e-03 | NA | 0.013 |
3. B | P20273 | B-cell receptor CD22 | 2.48e-04 | NA | 0.006 |
3. B | Q63111 | Carcinoembryonic antigen-related cell adhesion molecule 3 | 7.12e-07 | NA | 1.04e-08 |
3. B | A4FUY1 | Hepatocyte cell adhesion molecule | 9.85e-04 | NA | 0.006 |
3. B | O75871 | Carcinoembryonic antigen-related cell adhesion molecule 4 | 1.82e-04 | NA | 2.88e-06 |
3. B | Q90W79 | Contactin-5 | 1.42e-02 | NA | 0.017 |
3. B | Q14CZ8 | Hepatocyte cell adhesion molecule | 4.83e-03 | NA | 0.003 |
3. B | D3YZF7 | V-set and immunoglobulin domain-containing protein 10-like | 2.01e-03 | NA | 1.59e-04 |